Advanced search
Start date
Betweenand

Genetic Diversity non-polio enterovirus detected in patients with acute flaccid paralysis in São Paulo State.

Abstract

Acute flaccid paralysis (AFP) is the most common clinical presentation of the infection caused by the poliovirus 1, 2 and 3 (polio), occurring in 0.1-1% of infected cases. The measures implemented throughout the national territory to strengthen the epidemiological surveillance and laboratory, and intensive vaccination campaigns, since 1989 there is no detected of polio cases in the state of São Paulo, and in Brazil since 1990. In 1994, Brazil was certified like a country wild-poliovirus-free by the Pan American Health Organization (PAHO), together with the other countries of the Americas. With the eradication of wild poliovirus in Brazil and the Americas, the non-polio enteroviruses (NPEV) are becoming increasingly relevant importance in cases of acute flaccid paralysis. The epidemiological and laboratory surveillance of PFAs in the state of São Paulo has no data on the characterization of EVNP in serotypes. The development of the project will allow the monitoring and improvement in knowledge of the diversity of the serotypes of EVNP in our country, considered as one of the main etiological agents of AFPs, and improve the existing data from other regions of Brazil. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CARMONA, RITA C. C.; MACHADO, BRAULIO C.; REIS, FABRICIO C.; JORGE, ADRIANA M. V.; CILLI, AUDREY; DIAS, AMANDA M. N.; MORAIS, DANIELE R.; LEME, LUCAS; YU, ANA L. F.; SILVA, MARCELA R.; et al. Hand, foot, and mouth disease outbreak by Coxsackievirus A6 during COVID-19 pandemic in 2021, Sao Paulo, Brazil. Journal of Clinical Virology, v. 154, p. 4-pg., . (17/50333-7, 17/05350-0)